OHSU Cancer Institute research discovery opens new window to understanding chronic myeloi... ( ATLANTA Oregon Health & Science Uni...)

OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia

Date:12/9/2007

ATLANTA Oregon Health & Science University Cancer Institute researchers have opened a new window into the roots of chronic myeloid leukemia (CML).

We are looking under the surface of CML to understand better where the cancer is coming from. We have discovered abnormal cells in the early stem cell population in some CML patients, which dont belong to the CML clone. These are abnormal cells that are not part of the CML clone, said Thomas Bumm, M.D., OHSU Cancer Institute member.

This research will be presented at the American Society of Hematology annual meeting in Atlanta on Sunday, Dec. 9, at 4:30 p.m.

Bumm was looking into Philadelphia Chromosome-negative stem cells which he and others had thought would look like normal, healthy cells, and have normal chromosomes. (It has been known that the driving force of CML is the Philadelphia Chromosome-positive cancer cells.)

But no, these chromosome negative cells are not normal looking. We are seeing that there are other abnormal cells in the early stem cell population in the bone marrow of some CML patients that are Philadelphia Chromosome-negative. They have abnormalities such as the deletion of chromosome 7 or a duplication of chromosome 8, explained Bumm, a fellow in hematology/medical oncology, OHSU School of Medicine.

It is not known why patients with CML have these abnormal cells and to what extent. These newly discovered abnormal cells are also seen in other cancers such as myelodysplastic syndrome.

We are not yet sure about the extent of this problem. We do hope though that our studies into the stem cell compartment of CML patients might help to find new targets for CML therapy to cure this cancer, Bumm said.

Chronic myelogenous leukemia is a form of blood cancer characterized by the increased and unregulated growth of predominantly myeloid cells in the bone marrow and the accumulation of these cells in the blood.

The next
'/>"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome

Post Your Comments:

(Date:5/19/2013)... the heterogeneity the variety of genetic mutations of ... patients with the most common type of head and neck ... Cancer , investigators at Massachusetts General Hospital (MGH) and ... a better predictor of survival than most traditional risk factors ... of the head and neck. , "Our findings ...

(Date:5/19/2013)... May 19, 2013 Alonso Krangle LLP ... diving accident lawsuit on behalf of a-24-year-old financial ... into shallow water. The diving accident lawsuit, which was filed ... County, alleges the Defendant held the property out as a ... diving in the area. (Case No. 34556/12) , According to ...

(Date:5/19/2013)... (PRWEB) May 20, 2013 The three ... Summit Medical Group: David A. Abrutyn, M.D., Robert S. ... to see patients at their current location, 215 Union ... M.D., has expertise in sports medicine, with emphasis on ... pediatric, adolescent, and adult patients for a wide range ...

(Date:5/19/2013)... 2013 At a May 6th, ... Asian Pacific Physicians (NCAPIP), the Pacific Chronic Disease ... of Chronic Disease Directors (NACDD), presented a newly ... diabetes, and non-communicable diseases (NCDs) in the U.S. ... in the Hawaii Journal of Medicine and Public ...

(Date:5/19/2013)... HealthDay Reporter , , SATURDAY, May 18 ... those with Crohn,s disease overcome the fatigue and ... disease, according to new research. Extra vitamin ... and general fatigue, greater quality of life and ... said Tara Raftery, a research dietitian and doctoral ...

Breaking Medicine News(10 mins):Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2 Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3 Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2 Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3 Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2 Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3 Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2 Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3 Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2 Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3

[0] Genetic diversity within tumors predicts outcome in head and neck cancer [0] Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach [0] Summit Medical Group Welcomes the Center for Orthopedic Care [0] Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions [0] Extra Vitamin D May Ease Crohn's Symptoms, Study Finds

... ... law firm Galfand Berger, recently achieved the third largest civil damages award known in ... the job by a poorly designed machine. Attorney Jurewicz negotiated with the Austrian ... Galfand Berger,s client. , ...

... ... a simple spice from India has for more than 3500 years been inhibiting the actual ... Report" also shares how stem cells are currently being used to treat more than 89 ... ...

... , , As Congress ... Quadruple Over the Next Decade Without Action , WASHINGTON, Nov. ... that rising obesity rates will continue to be an increasing burden on ... "The Future Cost of Obesity: National and State Estimates of the Impact ...

... in the Journal of American College Health finds that ... more likely to binge drink each week than students placed in ... college campuses around the country participated in the study: , ... on a weekly basis. 18 percent of students in ...

... BERWYN, Pa., Nov. 16 Encorium Group, Inc. (Nasdaq: ... conducting studies in over 30 countries for many of the ... results for the third quarter ended September 30, 2009. , ... substantially all of the assets relating to its US line ...

... 16 The federal Centers for Disease Control and ... doses of H1N1 vaccine to Pennsylvania to date, the ... has been distributed to 1,312 certified providers including pediatricians, ... that agreed to target the groups of people considered ...

Galfand Berger Personal Injury Lawyer Richard Jurewicz Obtains Record Recovery In Berks County Turmeric-The Scientific Evidence How It Prevents And Treats Cancer & Dementia New Data Shows Obesity Costs Will Grow to $344 Billion by 2018 Coed college housing connected to frequent binge drinking Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting Department of Health Updates H1N1 Vaccine Distribution Effort, Reminds At-Risk Residents of Upcoming Vaccination Clinics

(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...

(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...

(Date:5/16/2013)... N.C. , May 16, 2013 Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...

Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3

[0] Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis [0] A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing [0] National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill

... obesity and,complications arising from popular aesthetic surgical procedure, ... study,investigating the relationship between complications of body contouring,surgery ... in the occurrence of,such complications with worsening degree ... the July/August 2008 issue of the Aesthetic Surgery,Journal, ...

... MOORESVILLE, N.C., July 30 Anpath Group, Inc.,(OTC ... owned,subsidiary, EnviroSystems, Inc. (ESI) announced that its EnviroTru(R),disinfectant ... Department of,Management Services (DMS) in the State of ... of Green, LLC(TM) ( http://www.aworldofgreen.com ),worked ...

Cached Medicine Technology:Body Contouring Surgery Risk Rises with Increased Body Mass Index 2 Body Contouring Surgery Risk Rises with Increased Body Mass Index 3 Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 2 Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 3

Body Contouring Surgery Risk Rises with Increased Body Mass Index Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida

The Unistik 3 family of single use safety lancets has 4 models for use across all clinical environments....

... complete range of needle sizes to ensure that ... be obtained with any skin type, quickly, easily ... of needle diameters enable users to obtain blood ... damage. This makes it easier to comply with ...

Lancets are the fine needles used with a lancing device to draw a blood sample for glucose testing. To make testing less painful, we developed lancets with extra-thin tips....

Medicine Products:

Unistik 3 range The Unilet range OneTouch® UltraSoft® Lancets OneTouch® Fine Point™ Lancets